Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangyu Peng

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Allergy and Clinical Immunology|January 14, 2015
Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skinJoel Correa da Rosa, Dana Malajian, Avner Shemer, et al.
The Journal of Investigative Dermatology|December 12, 2018
A Phase 2 Randomized Trial of Apremilast in Patients with Atopic DermatitisEric L Simpson, Shinichi Imafuku, Yves Poulin, et al.
The Journal of Allergy and Clinical Immunology|May 20, 2020
Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitisBenjamin Ungar, Ana B Pavel, Randall Li, et al.
The Journal of Allergy and Clinical Immunology|July 30, 2019
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitisAna B Pavel, Teresa Song, Hyun-Je Kim, et al.
The Journal of Allergy and Clinical Immunology|October 3, 2015
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarizationShinji Noda, Mayte Suárez-Fariñas, Benjamin Ungar, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosisAmy S Paller, Yael Renert-Yuval, Maria Suprun, et al.
The Journal of Allergy and Clinical Immunology|February 10, 2019
GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitisEmma Guttman-Yassky, Ana B Pavel, Lisa Zhou, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2018
Ichthyosis molecular fingerprinting shows profound T<sub>H</sub>17 skewing and a unique barrier genomic signatureKunal Malik, Helen He, Thy Nhat Huynh, et al.
The Journal of Allergy and Clinical Immunology|January 28, 2019
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitisLisa Zhou, Alexandra Leonard, Ana B Pavel, et al.
The Journal of Allergy and Clinical Immunology|September 9, 2018
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitisEmma Guttman-Yassky, Robert Bissonnette, Benjamin Ungar, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Allergy and Clinical Immunology|January 14, 2015
Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skinJoel Correa da Rosa, Dana Malajian, Avner Shemer, et al.
The Journal of Investigative Dermatology|December 12, 2018
A Phase 2 Randomized Trial of Apremilast in Patients with Atopic DermatitisEric L Simpson, Shinichi Imafuku, Yves Poulin, et al.
The Journal of Allergy and Clinical Immunology|May 20, 2020
Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitisBenjamin Ungar, Ana B Pavel, Randall Li, et al.
The Journal of Allergy and Clinical Immunology|July 30, 2019
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitisAna B Pavel, Teresa Song, Hyun-Je Kim, et al.
The Journal of Allergy and Clinical Immunology|October 3, 2015
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarizationShinji Noda, Mayte Suárez-Fariñas, Benjamin Ungar, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosisAmy S Paller, Yael Renert-Yuval, Maria Suprun, et al.
The Journal of Allergy and Clinical Immunology|February 10, 2019
GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitisEmma Guttman-Yassky, Ana B Pavel, Lisa Zhou, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2018
Ichthyosis molecular fingerprinting shows profound T<sub>H</sub>17 skewing and a unique barrier genomic signatureKunal Malik, Helen He, Thy Nhat Huynh, et al.
The Journal of Allergy and Clinical Immunology|January 28, 2019
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitisLisa Zhou, Alexandra Leonard, Ana B Pavel, et al.
The Journal of Allergy and Clinical Immunology|September 9, 2018
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitisEmma Guttman-Yassky, Robert Bissonnette, Benjamin Ungar, et al.
Pageof 5